1 |
10-mg dose of e5501-p21% powder |
- |
- |
- |
- |
063 [1] 63 💬 |
2 |
23-valent pneumococcal polysaccharide vaccine |
- |
- |
- |
- |
013 [3] 13, 46, 53 💬 |
3 |
23-valent pneumococcal polysaccharide vaccine (23-ppv) |
- |
- |
- |
- |
013 [1] 13 💬 |
4 |
23-valent polysaccharide pneumococcal vaccine |
- |
- |
- |
- |
096 [1] 96 💬 |
5 |
23-valent polysaccharide pneumococcal vaccine (pneumovax tm) |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
6 |
2l polyethylene glycol/ascorbic acid |
Ascorbic acid |
[2] D00018 D00018, D03370 D03370 💬 |
- |
- |
097 [1] 97 💬 |
7 |
5% lidocaine/5 mg/ml 0.02% estradiol compound cream |
Estradiol |
[11] D00105 D00105, D00358 D00358, D01413 D01413, D01617 D01617, D01953 D01953, D02086 D02086, D04061 D04061, D04063 D04063, D04064 D04064, D04065 D04065, D08127 D08127 💬 |
ESR1 [7] ESR1, ESR2, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [12] Adrenergic signaling in cardiomyocytes, Breast cancer, Dopaminergic synapse, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Taste transduction, Thyroid hormone signaling pathway |
226 [1] 226 💬 |
8 |
?-3 polyunsaturated fatty acid |
- |
- |
- |
- |
096 [1] 96 💬 |
9 |
[f-18] fluorodopa positron emission tomography |
- |
- |
- |
- |
006 [1] 6 💬 |
10 |
Advate 1000 iu powder and solvent for solution for injection |
- |
- |
- |
- |
288 [1] 288 💬 |
11 |
Advate 1000iu powder and solvent for solution for injection |
- |
- |
- |
- |
288 [1] 288 💬 |
12 |
Advate 500 iu powder and solvent for solution for injection |
- |
- |
- |
- |
288 [1] 288 💬 |
13 |
Alga dunaliella bardawil powder |
- |
- |
- |
- |
090 [1] 90 💬 |
14 |
Alicalm (polymeric liquid formula) |
- |
- |
- |
- |
096 [1] 96 💬 |
15 |
Alkalinized lidocaine-heparin |
Heparin |
[4] D00358 D00358, D02086 D02086, D07510 D07510, D08127 D08127 💬 |
SCN1A [6] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SERPINC1 💬 |
Adrenergic signaling in cardiomyocytes [4] Adrenergic signaling in cardiomyocytes, Complement and coagulation cascades, Dopaminergic synapse, Taste transduction |
226 [1] 226 💬 |
16 |
Allogeneic skin-derived abcb5-positive mesenchymal stem cells |
- |
- |
- |
- |
036 [1] 36 💬 |
17 |
American ginseng |
Ginseng |
[1] D06772 D06772 💬 |
- |
- |
013 [1] 13 💬 |
18 |
American ginseng extract ht-1001 |
Ginseng |
[1] D06772 D06772 💬 |
- |
- |
013 [1] 13 💬 |
19 |
Amoxicillin |
Amoxicillin |
[3] D00229 D00229, D02925 D02925, D07452 D07452 💬 |
- |
- |
006 [7] 6 , 46, 63, 96, 97, 222, 299 💬 |
20 |
Amoxicillin and clavulanic acid |
Amoxicillin |
[4] D00229 D00229, D02925 D02925, D07452 D07452, D07711 D07711 💬 |
- |
- |
299 [1] 299 💬 |
21 |
Amoxicillin and tetracycline |
Amoxicillin |
[4] D00201 D00201, D00229 D00229, D02925 D02925, D07452 D07452 💬 |
- |
- |
097 [1] 97 💬 |
22 |
Amoxicillin hydrate |
Amoxicillin |
[3] D00229 D00229, D02925 D02925, D07452 D07452 💬 |
- |
- |
063 [1] 63 💬 |
23 |
Amoxicillin, metronidazole and tetracycline |
Amoxicillin |
[7] D00201 D00201, D00229 D00229, D00409 D00409, D02925 D02925, D05016 D05016, D05017 D05017, D07452 D07452 💬 |
- |
- |
097 [1] 97 💬 |
24 |
Apomorphine hydrochloride 1.8mg inhalation powder, pre-dispensed |
Apomorphine |
[2] D02004 D02004, D07460 D07460 💬 |
DRD1 [2] DRD1, DRD2 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
25 |
Apomorphine hydrochloride 2.8mg inhalation powder, pre-dispensed |
Apomorphine |
[2] D02004 D02004, D07460 D07460 💬 |
DRD1 [2] DRD1, DRD2 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
26 |
Apomorphine hydrochloride 4.0 mg inhalation powder, pre-dispensed |
Apomorphine |
[2] D02004 D02004, D07460 D07460 💬 |
DRD1 [2] DRD1, DRD2 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
27 |
Apomorphine hydrochloride 5.8 mg inhalation powder, pre-dispensed |
Apomorphine |
[2] D02004 D02004, D07460 D07460 💬 |
DRD1 [2] DRD1, DRD2 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
28 |
Apomorphine nasal powder |
Apomorphine |
[2] D02004 D02004, D07460 D07460 💬 |
DRD1 [2] DRD1, DRD2 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
29 |
Autologous ovalbumin-specific type 1 regulatory t lymphocytes expanded population |
- |
- |
- |
- |
096 [1] 96 💬 |
30 |
Autologous vitd3 tolerogenic monocyte-derived dendritic cells loaded with a pool of myelin peptides (toldc-vitd3) |
- |
- |
- |
- |
013 [1] 13 💬 |
31 |
Avian polyclonal igy antibody against pa |
- |
- |
- |
- |
299 [1] 299 💬 |
32 |
Behavioral: flexibility and postural exercise |
- |
- |
- |
- |
299 [1] 299 💬 |
33 |
Behavioral: posture training |
- |
- |
- |
- |
046 [1] 46 💬 |
34 |
Benlysta - 120 mg - polvere per concentrato per soluzione per infusione - uso endovenoso - flaconcino (vetro) 120 mg 1 flaconcino |
- |
- |
- |
- |
053 [1] 53 💬 |
35 |
Benlysta 400 mg powder for concentrate for solution for infusion |
- |
- |
- |
- |
043 [2] 43, 49 💬 |
36 |
Benlysta 400 mg powder for concentrate for solution for infusions |
- |
- |
- |
- |
049 [1] 49 💬 |
37 |
Benlysta 400mg polvere per concentrato per soluzione per infusione |
- |
- |
- |
- |
043 [1] 43 💬 |
38 |
Berberine |
Berberine |
[1] D00092 D00092 💬 |
- |
- |
097 [1] 97 💬 |
39 |
Berberine chloride |
Berberine |
[1] D00092 D00092 💬 |
- |
- |
097 [1] 97 💬 |
40 |
Betaferon 250 microgram/ml, powder and solvent for solution for injection |
- |
- |
- |
- |
013 [1] 13 💬 |
41 |
Betaferon 250 microgram/ml, powder and solvent for solution for injection. |
- |
- |
- |
- |
013 [1] 13 💬 |
42 |
Bladder instillation with heparin/ lidocaine |
Heparin |
[4] D00358 D00358, D02086 D02086, D07510 D07510, D08127 D08127 💬 |
SCN1A [6] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SERPINC1 💬 |
Adrenergic signaling in cardiomyocytes [4] Adrenergic signaling in cardiomyocytes, Complement and coagulation cascades, Dopaminergic synapse, Taste transduction |
226 [1] 226 💬 |
43 |
Brimonidine tartrate posterior segment drug delivery system (brimo ps dds) applicator system |
Brimonidine |
[2] D02076 D02076, D07540 D07540 💬 |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
090 [1] 90 💬 |
44 |
Bydureon 2 mg powder and solvent for prolonged-release suspension |
- |
- |
- |
- |
006 [1] 6 💬 |
45 |
C-type natriuretic peptide conjugated to multi-arm polyethylene glycol carrier through a cleavable linker |
Polyethylene glycol |
[1] D03370 D03370 💬 |
- |
- |
276 [1] 276 💬 |
46 |
Calcium lactate |
Calcium |
[2] D00936 D00936, D02254 D02254 💬 |
- |
- |
235 [1] 235 💬 |
47 |
Cayston aztreonam 75 mg powder and solvent for nebuliser solution |
Aztreonam |
[2] D00240 D00240, D06558 D06558 💬 |
- |
- |
299 [1] 299 💬 |
48 |
Ceftazidim fresenius kabi 2000 mg poeder voor oplossing voor injectie of infusie |
Ceftazidime |
[2] D00921 D00921, D07654 D07654 💬 |
- |
- |
299 [1] 299 💬 |
49 |
Ceftazidime and tobramycin |
Ceftazidime |
[4] D00063 D00063, D00921 D00921, D02542 D02542, D07654 D07654 💬 |
- |
- |
299 [1] 299 💬 |
50 |
Ceramic on polyethylene articulation |
- |
- |
- |
- |
046 [1] 46 💬 |
51 |
Cftr potentiator |
- |
- |
- |
- |
299 [1] 299 💬 |
52 |
Ciprofloxacin (bayq3939) dry powder for inhalation |
Ciprofloxacin |
[2] D00186 D00186, D02216 D02216 💬 |
- |
- |
299 [1] 299 💬 |
53 |
Clartihromycin, amoxicillin, and omeprazole |
Amoxicillin |
[7] D00229 D00229, D00455 D00455, D01207 D01207, D02925 D02925, D05259 D05259, D05261 D05261, D07452 D07452 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
006 [1] 6 💬 |
54 |
Cohort 1: 1.0 x 10^8 polytregs |
- |
- |
- |
- |
035 [1] 35 💬 |
55 |
Cohort 2: 2.5x10^8 polytregs |
- |
- |
- |
- |
035 [1] 35 💬 |
56 |
Colimicina - 1000000 u/4 ml polvere e solvente per soluzione iniettabile per uso intramuscolare1 flaconcino polvere + 1 fiala solvente 4 ml |
- |
- |
- |
- |
299 [1] 299 💬 |
57 |
Combination product: device: axially oscillating sphere dry powder inhaler (aos dpi) |
- |
- |
- |
- |
086 [1] 86 💬 |
58 |
Comparator: diclofenac |
Diclofenac |
[3] D00903 D00903, D00904 D00904, D07816 D07816 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
046 [1] 46 💬 |
59 |
Comparator: diclofenac sodium |
Diclofenac |
[3] D00903 D00903, D00904 D00904, D07816 D07816 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
046 [1] 46 💬 |
60 |
Cyclophosphamide post transplant |
Cyclophosphamide |
[2] D00287 D00287, D07760 D07760 💬 |
- |
- |
065 [1] 65 💬 |
61 |
Cyclosporine a dry powder inhalation (drug) |
Cyclosporine |
[1] D00184 D00184 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
228 [1] 228 💬 |
62 |
Device: four-point cane (fpc) |
- |
- |
- |
- |
013 [1] 13 💬 |
63 |
Device: generic dry powder inhaler |
- |
- |
- |
- |
086 [1] 86 💬 |
64 |
Device: metal on polyethylene articulation |
- |
- |
- |
- |
046 [1] 46 💬 |
65 |
Device: nocturnal oxygen , nocturnal bi-level positive pressure ventilation |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
299 [1] 299 💬 |
66 |
Device: poly-l-lactic acid |
L-Lactic acid |
[1] D00111 D00111 💬 |
- |
- |
265 [1] 265 💬 |
67 |
Device: positive expiratory pressure |
- |
- |
- |
- |
299 [1] 299 💬 |
68 |
Device: powerlung trainer |
- |
- |
- |
- |
002 [1] 2 💬 |
69 |
Device: scorpio nrg posterior stabilized (ps) |
- |
- |
- |
- |
046 [1] 46 💬 |
70 |
Device: serial night time position splint |
- |
- |
- |
- |
051 [1] 51 💬 |
71 |
Device: single-point cane (spc) |
- |
- |
- |
- |
013 [1] 13 💬 |
72 |
Device: tobi podhaler |
- |
- |
- |
- |
299 [1] 299 💬 |
73 |
Device: trekking pole (tp). |
- |
- |
- |
- |
013 [1] 13 💬 |
74 |
Dexamethasone oral tablet 8mg (dexamethasone krka tablets(8mg), warsaw, poland). |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
235 [1] 235 💬 |
75 |
Dextromethorphan |
Dextromethorphan |
[3] D00848 D00848, D03742 D03742, D03744 D03744 💬 |
GRIN1 [6] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 |
Alcoholism [20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
002 [11] 2 , 6 , 8 , 13, 21, 46, 78, 85, 96, 97, 156 💬 |
76 |
Dextromethorphan 30 mg |
Dextromethorphan |
[3] D00848 D00848, D03742 D03742, D03744 D03744 💬 |
GRIN1 [6] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 |
Alcoholism [20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
096 [2] 96, 97 💬 |
77 |
Dextromethorphan and caffeine |
Caffeine |
[5] D00528 D00528, D00848 D00848, D01453 D01453, D03742 D03742, D03744 D03744 💬 |
ADORA1 [17] ADORA1, ADORA2A, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A, SIGMAR1 💬 |
Alcoholism [37] Alcoholism, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Apelin signaling pathway, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Huntington disease, Insulin signaling pathway, Long-term potentiation, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
078 [1] 78 💬 |
78 |
Dextromethorphan hbr and quinidine sulfate |
Dextromethorphan |
[7] D00642 D00642, D00643 D00643, D00848 D00848, D02272 D02272, D03742 D03742, D03744 D03744, D08458 D08458 💬 |
GRIN1 [11] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 |
Adrenergic signaling in cardiomyocytes [22] Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway |
002 [1] 2 💬 |
79 |
Dextromethorphan hydrobromide |
Dextromethorphan |
[3] D00848 D00848, D03742 D03742, D03744 D03744 💬 |
GRIN1 [6] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 |
Alcoholism [20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
013 [2] 13, 46 💬 |
80 |
Dextromethorphan hydrobromide 20 mg and quinidine sulfate 10 mg |
Dextromethorphan |
[7] D00642 D00642, D00643 D00643, D00848 D00848, D02272 D02272, D03742 D03742, D03744 D03744, D08458 D08458 💬 |
GRIN1 [11] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 |
Adrenergic signaling in cardiomyocytes [22] Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway |
002 [2] 2 , 13 💬 |
81 |
Dextromethorphan hydrobromide 30 mg and quinidine sulfate 10 mg |
Dextromethorphan |
[7] D00642 D00642, D00643 D00643, D00848 D00848, D02272 D02272, D03742 D03742, D03744 D03744, D08458 D08458 💬 |
GRIN1 [11] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 |
Adrenergic signaling in cardiomyocytes [22] Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway |
002 [2] 2 , 13 💬 |
82 |
Dextromethorphan/quinidine |
Dextromethorphan |
[7] D00642 D00642, D00643 D00643, D00848 D00848, D02272 D02272, D03742 D03742, D03744 D03744, D08458 D08458 💬 |
GRIN1 [11] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 |
Adrenergic signaling in cardiomyocytes [22] Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway |
013 [1] 13 💬 |
83 |
Dextromethorphan/quinidine 20mg/10mg (dm/q 20mg/10mg) |
Dextromethorphan |
[7] D00642 D00642, D00643 D00643, D00848 D00848, D02272 D02272, D03742 D03742, D03744 D03744, D08458 D08458 💬 |
GRIN1 [11] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 |
Adrenergic signaling in cardiomyocytes [22] Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway |
008 [1] 8 💬 |
84 |
Diagnostic test: endogenous thrombin potential |
Thrombin |
[1] D00090 D00090 💬 |
- |
- |
086 [2] 86, 88 💬 |
85 |
Diagnostic test: positive and negative affect scale (panas) |
- |
- |
- |
- |
006 [1] 6 💬 |
86 |
Diagnostic test: postoperative laboratory blood tests at 24 hour |
- |
- |
- |
- |
235 [1] 235 💬 |
87 |
Diagnostic test: postoperative laboratory blood tests at 6 hour |
- |
- |
- |
- |
235 [1] 235 💬 |
88 |
Diagnostic test: postoperative laboratory drainage fluid tests at 24 hour |
- |
- |
- |
- |
235 [1] 235 💬 |
89 |
Diclofenac |
Diclofenac |
[3] D00903 D00903, D00904 D00904, D07816 D07816 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 [4] 13, 34, 46, 271 💬 |
90 |
Diclofenac + omeprazole |
Diclofenac |
[7] D00455 D00455, D00903 D00903, D00904 D00904, D01207 D01207, D05259 D05259, D05261 D05261, D07816 D07816 💬 |
ATP4A [4] ATP4A, ATP4B, PTGS1, PTGS2 💬 |
Alzheimer disease [26] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Collecting duct acid secretion, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
046 [1] 46 💬 |
91 |
Diclofenac 50 milligrams |
Diclofenac |
[3] D00903 D00903, D00904 D00904, D07816 D07816 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
271 [1] 271 💬 |
92 |
Diclofenac sodium |
Diclofenac |
[3] D00903 D00903, D00904 D00904, D07816 D07816 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
034 [2] 34, 46 💬 |
93 |
Diclofenac sodium topical gel |
Diclofenac |
[3] D00903 D00903, D00904 D00904, D07816 D07816 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 [1] 13 💬 |
94 |
Diclofenac sr |
Diclofenac |
[3] D00903 D00903, D00904 D00904, D07816 D07816 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
271 [1] 271 💬 |
95 |
Dimebon + dextromethorphan |
Dextromethorphan |
[4] D00848 D00848, D03742 D03742, D03744 D03744, D09917 D09917 💬 |
ACHE [7] ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 |
Alcoholism [22] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
008 [1] 8 💬 |
96 |
Diosminex, 500 mg, tabletki powlekane |
- |
- |
- |
- |
265 [1] 265 💬 |
97 |
Dry powder tobramycin |
Tobramycin |
[2] D00063 D00063, D02542 D02542 💬 |
- |
- |
299 [1] 299 💬 |
98 |
Egg albumen powder |
Egg |
- |
- |
- |
096 [1] 96 💬 |
99 |
Enbrel 25 mg powder and solvent for solution for injection |
- |
- |
- |
- |
046 [1] 46 💬 |
100 |
Enbrel 50 mg powder and solvent for solution for injection |
- |
- |
- |
- |
046 [1] 46 💬 |
101 |
Esomeprazole |
Esomeprazole |
[4] D01984 D01984, D04056 D04056, D07917 D07917, D09339 D09339 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
013 [6] 13, 46, 86, 98, 298, 299 💬 |
102 |
Esomeprazole 20 mg |
Esomeprazole |
[4] D01984 D01984, D04056 D04056, D07917 D07917, D09339 D09339 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
046 [1] 46 💬 |
103 |
Ezogabine |
Ezogabine |
[1] D09569 D09569 💬 |
KCNQ1 [5] KCNQ1, KCNQ2, KCNQ3, KCNQ4, KCNQ5 💬 |
Adrenergic signaling in cardiomyocytes [6] Adrenergic signaling in cardiomyocytes, Cholinergic synapse, Gastric acid secretion, Pancreatic secretion, Protein digestion and absorption, Vibrio cholerae infection |
002 [2] 2 , 144 💬 |
104 |
Ezogabine (us only) |
Ezogabine |
[1] D09569 D09569 💬 |
KCNQ1 [5] KCNQ1, KCNQ2, KCNQ3, KCNQ4, KCNQ5 💬 |
Adrenergic signaling in cardiomyocytes [6] Adrenergic signaling in cardiomyocytes, Cholinergic synapse, Gastric acid secretion, Pancreatic secretion, Protein digestion and absorption, Vibrio cholerae infection |
144 [1] 144 💬 |
105 |
Ezogabine/retigabine |
Ezogabine |
[1] D09569 D09569 💬 |
KCNQ1 [5] KCNQ1, KCNQ2, KCNQ3, KCNQ4, KCNQ5 💬 |
Adrenergic signaling in cardiomyocytes [6] Adrenergic signaling in cardiomyocytes, Cholinergic synapse, Gastric acid secretion, Pancreatic secretion, Protein digestion and absorption, Vibrio cholerae infection |
144 [1] 144 💬 |
106 |
Fabrazyme - 35 mg polvere per concentrato per soluzione per infusione endovenosa 1 flaconcino |
- |
- |
- |
- |
019 [1] 19 💬 |
107 |
Fenfluramine |
Fenfluramine |
[1] D07945 D07945 💬 |
HTR2A [4] HTR2A, HTR2B, HTR2C, SLC6A4 💬 |
Calcium signaling pathway [6] Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle |
140 [3] 140, 144, 145 💬 |
108 |
Fenfluramine hcl, dl-fenfluramine, (±)-fenfluramine |
Fenfluramine |
[1] D07945 D07945 💬 |
HTR2A [4] HTR2A, HTR2B, HTR2C, SLC6A4 💬 |
Calcium signaling pathway [6] Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle |
144 [1] 144 💬 |
109 |
Fenfluramine hydrochloride |
Fenfluramine |
[1] D07945 D07945 💬 |
HTR2A [4] HTR2A, HTR2B, HTR2C, SLC6A4 💬 |
Calcium signaling pathway [6] Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle |
140 [2] 140, 144 💬 |
110 |
Fenfluramine hydrochloride (colorless) |
Fenfluramine |
[1] D07945 D07945 💬 |
HTR2A [4] HTR2A, HTR2B, HTR2C, SLC6A4 💬 |
Calcium signaling pathway [6] Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle |
140 [2] 140, 144 💬 |
111 |
Fenfluramine hydrochloride (red) |
Fenfluramine |
[1] D07945 D07945 💬 |
HTR2A [4] HTR2A, HTR2B, HTR2C, SLC6A4 💬 |
Calcium signaling pathway [6] Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle |
140 [1] 140 💬 |
112 |
Fetal porcine cells, neurocell-pd |
- |
- |
- |
- |
006 [1] 6 💬 |
113 |
Finely ground flaxseed powder |
- |
- |
- |
- |
299 [1] 299 💬 |
114 |
Flucloxacillin 250mg/5ml sugar-free powder for oral solution |
Flucloxacillin |
[3] D01249 D01249, D04196 D04196, D07965 D07965 💬 |
- |
- |
299 [1] 299 💬 |
115 |
Fluticasone propionate, 800 mcg twice daily (post 4fed failure) |
Fluticasone |
[2] D01708 D01708, D07981 D07981 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
098 [1] 98 💬 |
116 |
Forlax 4 g, poudre pour solution buvable en sachet |
- |
- |
- |
- |
299 [1] 299 💬 |
117 |
Freeze-dried black raspberry powder |
Raspberry |
- |
- |
- |
097 [1] 97 💬 |
118 |
Genetic: polymerase chain reaction |
- |
- |
- |
- |
028 [2] 28, 60 💬 |
119 |
Genetic: polymorphism analysis |
- |
- |
- |
- |
049 [2] 49, 60 💬 |
120 |
Genotonorm kabipen 5.3 mg polvo y disolvente para sol. inyectable (marca internacional genotropin) |
- |
- |
- |
- |
078 [1] 78 💬 |
121 |
Genotonorm kabipen 5.3 mg polvo y disolvente para solución inyectable (marca internacional genotropin) |
- |
- |
- |
- |
078 [1] 78 💬 |
122 |
Genotropin 12 mg powder and solvent for solution for injection. |
- |
- |
- |
- |
078 [1] 78 💬 |
123 |
Ginger |
Ginger |
[1] D06744 D06744 💬 |
- |
- |
046 [1] 46 💬 |
124 |
Ginseng |
Ginseng |
[1] D06772 D06772 💬 |
- |
- |
013 [3] 13, 46, 53 💬 |
125 |
Green tea polyphenols (egcg/ecg) |
Epigallocatechin gallate |
[1] D06903 D06903 💬 |
- |
- |
006 [1] 6 💬 |
126 |
Haploidentical hsct using tbi free regimen, ''atg'' with ''post transplant cyclophosphamide'' |
Cyclophosphamide |
[2] D00287 D00287, D07760 D07760 💬 |
- |
- |
060 [1] 60 💬 |
127 |
Heparin & alkalinized lidocaine bladder instillation |
Heparin |
[4] D00358 D00358, D02086 D02086, D07510 D07510, D08127 D08127 💬 |
SCN1A [6] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SERPINC1 💬 |
Adrenergic signaling in cardiomyocytes [4] Adrenergic signaling in cardiomyocytes, Complement and coagulation cascades, Dopaminergic synapse, Taste transduction |
226 [1] 226 💬 |
128 |
Heparin 25mg inhalation powder, hard capsule |
Heparin |
[1] D07510 D07510 💬 |
SERPINC1 [1] SERPINC1 💬 |
Complement and coagulation cascades [1] Complement and coagulation cascades |
299 [1] 299 💬 |
129 |
Histamine |
Histamine |
[1] D08040 D08040 💬 |
HRH1 [4] HRH1, HRH2, HRH3, HRH4 💬 |
Calcium signaling pathway [4] Calcium signaling pathway, Gastric acid secretion, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
013 [1] 13 💬 |
130 |
Human dermal fibroblasts cultured on a bioresorbable polyglactin mesh |
- |
- |
- |
- |
036 [1] 36 💬 |
131 |
Hydroxychloroquine |
Hydroxychloroquine |
[1] D08050 D08050 💬 |
- |
- |
013 [23] 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 66, 84, 89, 90, 96, 218, 222, 234, 254, 271, 298, 299 💬 |
132 |
Hydroxychloroquine (z0188) |
Hydroxychloroquine |
[1] D08050 D08050 💬 |
- |
- |
049 [1] 49 💬 |
133 |
Hydroxychloroquine + prednisone |
Hydroxychloroquine |
[2] D00473 D00473, D08050 D08050 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
084 [1] 84 💬 |
134 |
Hydroxychloroquine high |
Hydroxychloroquine |
[1] D08050 D08050 💬 |
- |
- |
049 [1] 49 💬 |
135 |
Hydroxychloroquine higher dose |
Hydroxychloroquine |
[1] D08050 D08050 💬 |
- |
- |
090 [1] 90 💬 |
136 |
Hydroxychloroquine lower dose |
Hydroxychloroquine |
[1] D08050 D08050 💬 |
- |
- |
090 [1] 90 💬 |
137 |
Hydroxychloroquine or chloroquine |
Chloroquine |
[4] D02125 D02125, D02366 D02366, D03469 D03469, D08050 D08050 💬 |
- |
- |
049 [1] 49 💬 |
138 |
Hydroxychloroquine reduced |
Hydroxychloroquine |
[1] D08050 D08050 💬 |
- |
- |
049 [1] 49 💬 |
139 |
Hydroxychloroquine sulfate |
Hydroxychloroquine |
[1] D08050 D08050 💬 |
- |
- |
046 [2] 46, 66 💬 |
140 |
Hydroxychloroquine sulphate |
Hydroxychloroquine |
[1] D08050 D08050 💬 |
- |
- |
096 [1] 96 💬 |
141 |
Idpm: inhaled dry powder mannitol |
Mannitol |
[1] D00062 D00062 💬 |
- |
- |
299 [1] 299 💬 |
142 |
Iduronate-2-sulfatase fused to a fc polypeptide that binds to the human transferrin receptor |
- |
- |
- |
- |
019 [1] 19 💬 |
143 |
Immediate post operative bioassay of parathyroid hormone |
Parathyroid hormone |
[1] D05364 D05364 💬 |
PTH1R [2] PTH1R, PTH2R 💬 |
Endocrine and other factor-regulated calcium reabsorption [3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
235 [1] 235 💬 |
144 |
Inflectra 100 mg powder for concentrate for solution for infusion |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
145 |
Inhaled dry powder mannitol |
Mannitol |
[1] D00062 D00062 💬 |
- |
- |
299 [1] 299 💬 |
146 |
Inhaled dry powder treprostinil (liq861) |
Treprostinil |
[1] D06213 D06213 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
147 |
Inhaled tobramycin |
Tobramycin |
[2] D00063 D00063, D02542 D02542 💬 |
- |
- |
299 [1] 299 💬 |
148 |
Iv tobramycin |
Tobramycin |
[2] D00063 D00063, D02542 D02542 💬 |
- |
- |
299 [1] 299 💬 |
149 |
Jinarc - 15 mg +45 mg - compressa - uso orale - blister(alu/pvc) in confezione a portafoglio - 56 compresse (28x15 mg + 28 x 45 mg) |
- |
- |
- |
- |
067 [1] 67 💬 |
150 |
Jinarc - 30 mg + 60 mg - compressa - uso orale - blister(alu/pvc) in confezione a portafoglio - 56 compresse (28 x 30 mg + 28 x 60 mg) |
- |
- |
- |
- |
067 [1] 67 💬 |
151 |
Jinarc - 30 mg +90 mg - compressa - uso orale - blister(alu/pvc) in confezione a portafoglio - 56 compresse (28 x 30 mg + 28 x 90 mg) |
- |
- |
- |
- |
067 [1] 67 💬 |
152 |
Korean red ginseng |
Ginseng |
[1] D06772 D06772 💬 |
- |
- |
053 [1] 53 💬 |
153 |
Lansoprazole, amoxicillin, clarithromycin |
Amoxicillin |
[5] D00229 D00229, D00276 D00276, D00355 D00355, D02925 D02925, D07452 D07452 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
222 [1] 222 💬 |
154 |
Leflunomide-sulfasalazine-hydroxychloroquine |
Hydroxychloroquine |
[3] D00448 D00448, D00749 D00749, D08050 D08050 💬 |
DHODH [1] DHODH 💬 |
Biosynthesis of cofactors [3] Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism |
046 [1] 46 💬 |
155 |
Lenabasum 20 mg powder in capsule |
- |
- |
- |
- |
051 [1] 51 💬 |
156 |
Lenabasum 5 mg powder in capsule |
- |
- |
- |
- |
051 [1] 51 💬 |
157 |
Levodopa powder for inhalation |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
158 |
Licorice |
Licorice |
[1] D04365 D04365 💬 |
- |
- |
053 [1] 53 💬 |
159 |
Lidocaine |
Lidocaine |
[3] D00358 D00358, D02086 D02086, D08127 D08127 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
006 [10] 6 , 13, 34, 46, 51, 86, 168, 226, 231, 256 💬 |
160 |
Lidocaine 1% injectable solution |
Lidocaine |
[3] D00358 D00358, D02086 D02086, D08127 D08127 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
034 [1] 34 💬 |
161 |
Lidocaine 2% without vessel constrictor |
Lidocaine |
[3] D00358 D00358, D02086 D02086, D08127 D08127 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
051 [1] 51 💬 |
162 |
Lidocaine injection 2% |
Lidocaine |
[3] D00358 D00358, D02086 D02086, D08127 D08127 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
168 [1] 168 💬 |
163 |
Lidocaine patch 5% |
Lidocaine |
[3] D00358 D00358, D02086 D02086, D08127 D08127 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
013 [1] 13 💬 |
164 |
Lidocaine releasing intravesical system - liris® |
Lidocaine |
[3] D00358 D00358, D02086 D02086, D08127 D08127 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
226 [1] 226 💬 |
165 |
Liposomed polyphenols resveratrol and curcumin |
Curcumin |
- |
- |
- |
002 [1] 2 💬 |
166 |
Liprotamase powder for oral solution |
- |
- |
- |
- |
299 [1] 299 💬 |
167 |
Lisinopril, losartan, and atorvastatin |
Atorvastatin |
[7] D00258 D00258, D00357 D00357, D00362 D00362, D00887 D00887, D07474 D07474, D08131 D08131, D08146 D08146 💬 |
ACE [3] ACE, AGTR1, HMGCR 💬 |
AGE-RAGE signaling pathway in diabetic complications [22] AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Bile secretion, Calcium signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Terpenoid backbone biosynthesis, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
222 [1] 222 💬 |
168 |
Local anesthesia (lidocaine hydrochloride) |
Lidocaine |
[3] D00358 D00358, D02086 D02086, D08127 D08127 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
006 [1] 6 💬 |
169 |
Losartan |
Losartan |
[2] D00357 D00357, D08146 D08146 💬 |
AGTR1 [1] AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬 |
170 |
Losartan and atenolol or propranolol |
Atenolol |
[5] D00235 D00235, D00357 D00357, D00483 D00483, D08146 D08146, D08443 D08443 💬 |
ADRB1 [4] ADRB1, ADRB2, ADRB3, AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications [22] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Renin-angiotensin system, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
167 [1] 167 💬 |
171 |
Losartan and nebivolol |
Losartan |
[3] D00357 D00357, D05127 D05127, D08146 D08146 💬 |
ADRB1 [2] ADRB1, AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications [21] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Renin-angiotensin system, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
167 [1] 167 💬 |
172 |
Losartan and other angiotensin receptor blockers |
Angiotensin II |
[4] D00150 D00150, D00357 D00357, D02014 D02014, D08146 D08146 💬 |
AGTR1 [2] AGTR1, AGTR2 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
019 [1] 19 💬 |
173 |
Losartan bluefish 50 mg |
Bluefish |
[2] D00357 D00357, D08146 D08146 💬 |
AGTR1 [1] AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
058 [1] 58 💬 |
174 |
Losartan hexal |
Losartan |
[2] D00357 D00357, D08146 D08146 💬 |
AGTR1 [1] AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
036 [1] 36 💬 |
175 |
Losartan potasico |
Losartan |
[2] D00357 D00357, D08146 D08146 💬 |
AGTR1 [1] AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
179 [1] 179 💬 |
176 |
Losartan potassium |
Losartan |
[3] D00357 D00357, D08146 D08146, D08403 D08403 💬 |
AGTR1 [1] AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
036 [5] 36, 98, 167, 179, 215 💬 |
177 |
Losartan tablets & qingremoshen granule |
Losartan |
[2] D00357 D00357, D08146 D08146 💬 |
AGTR1 [1] AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
222 [1] 222 💬 |
178 |
Lym-x-sorb powder |
- |
- |
- |
- |
299 [1] 299 💬 |
179 |
Lyophilized etanercept powder(yisaipu) |
Etanercept |
[1] D00742 D00742 💬 |
LTA [2] LTA, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
271 [1] 271 💬 |
180 |
Mango polyphenolics |
Mango |
- |
- |
- |
096 [2] 96, 97 💬 |
181 |
Mannitol inhalation powder |
Mannitol |
[1] D00062 D00062 💬 |
- |
- |
299 [1] 299 💬 |
182 |
Meningococcal polysaccharide diphtheria conjugate vaccine (quadrivalent) |
- |
- |
- |
- |
013 [1] 13 💬 |
183 |
Meropenem fresenius kabi 1 g poeder voor oplossing voor injectie of infusie |
Meropenem |
[2] D02222 D02222, D08185 D08185 💬 |
- |
- |
299 [1] 299 💬 |
184 |
Methotrexate + salazopyrine + hydroxychloroquine administration |
Hydroxychloroquine |
[3] D00142 D00142, D02115 D02115, D08050 D08050 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
185 |
Methotrexate-sulfasalazine-hydroxychloroquine |
Hydroxychloroquine |
[4] D00142 D00142, D00448 D00448, D02115 D02115, D08050 D08050 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
186 |
Methylprednisolone po |
Methylprednisolone |
[6] D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
013 [1] 13 💬 |
187 |
Micellar paclitaxel for injection |
Paclitaxel |
[2] D00491 D00491, D05333 D05333 💬 |
TUBB [9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 |
Alzheimer disease [10] Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection |
046 [1] 46 💬 |
188 |
Mogamulizumab |
Mogamulizumab |
[1] D09761 D09761 💬 |
CCR4 [1] CCR4 💬 |
Chemokine signaling pathway [5] Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Kaposi sarcoma-associated herpesvirus infection, Viral carcinogenesis, Viral protein interaction with cytokine and cytokine receptor |
026 [1] 26 💬 |
189 |
Multigrain powder (s) |
- |
- |
- |
- |
046 [1] 46 💬 |
190 |
Myelostim 34 milions ui/ml - powder and solvent for solution for injection/infusion |
- |
- |
- |
- |
065 [1] 65 💬 |
191 |
Myelostim 34 milions ui/ml, powder and solvent for solution for injection or infusion |
- |
- |
- |
- |
065 [1] 65 💬 |
192 |
Myozyme 50 mg powder for concentrate for solution for infusion |
- |
- |
- |
- |
256 [1] 256 💬 |
193 |
Nebcin (tobramycin) |
Tobramycin |
[2] D00063 D00063, D02542 D02542 💬 |
- |
- |
299 [1] 299 💬 |
194 |
Nebulization tobramycin |
Tobramycin |
[2] D00063 D00063, D02542 D02542 💬 |
- |
- |
299 [1] 299 💬 |
195 |
Nexium (esomeprazole magnesium) |
Esomeprazole |
[4] D01984 D01984, D04056 D04056, D07917 D07917, D09339 D09339 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
298 [1] 298 💬 |
196 |
Nicotine |
Nicotine |
[3] D03365 D03365, D05156 D05156, D05157 D05157 💬 |
CHRNA1 [16] CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬 |
Alzheimer disease [7] Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases |
006 [2] 6 , 84 💬 |
197 |
Nicotine gum |
Nicotine |
[3] D03365 D03365, D05156 D05156, D05157 D05157 💬 |
CHRNA1 [16] CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬 |
Alzheimer disease [7] Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases |
006 [1] 6 💬 |
198 |
Nicotine nasal spray 10 mg/ml (0.5 mg/spray) |
Nicotine |
[3] D03365 D03365, D05156 D05156, D05157 D05157 💬 |
CHRNA1 [16] CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬 |
Alzheimer disease [7] Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases |
006 [1] 6 💬 |
199 |
Nicotine patch |
Nicotine |
[3] D03365 D03365, D05156 D05156, D05157 D05157 💬 |
CHRNA1 [16] CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬 |
Alzheimer disease [7] Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases |
006 [2] 6 , 84 💬 |
200 |
Nicotine transdermal patch |
Nicotine |
[3] D03365 D03365, D05156 D05156, D05157 D05157 💬 |
CHRNA1 [16] CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬 |
Alzheimer disease [7] Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases |
006 [1] 6 💬 |
201 |
Nplate 500 microgramos polvo para solución inyectable |
- |
- |
- |
- |
063 [1] 63 💬 |
202 |
Nucala 100 mg powder for solution for injection |
- |
- |
- |
- |
044 [2] 44, 45 💬 |
203 |
Octanate 100 ui/ml, poudre et solvant pour solution injectable |
Beroctocog alfa |
- |
- |
- |
288 [1] 288 💬 |
204 |
Octanate 50 ui/ml, poudre et solvant pour solution injectable |
Beroctocog alfa |
- |
- |
- |
288 [1] 288 💬 |
205 |
Oligog dry powder for inhalation |
- |
- |
- |
- |
299 [1] 299 💬 |
206 |
Open label rad001 (only used for post-extension phase) |
- |
- |
- |
- |
158 [1] 158 💬 |
207 |
Oral 5-asa+/-topical 5-asa+iv corticosteroids / po methylprednisolone |
Mesalazine |
[7] D00377 D00377, D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
208 |
Orencia 250 mg polvo para concentrado para sol. para perfusión |
- |
- |
- |
- |
046 [1] 46 💬 |
209 |
Orencia 250mg powder for concentrate for solution for infusion |
- |
- |
- |
- |
046 [1] 46 💬 |
210 |
Other: 100% pomegranate juice |
Pomegranate |
- |
- |
- |
096 [2] 96, 97 💬 |
211 |
Other: 4 food elimination diet (post 1fed failure) |
- |
- |
- |
- |
098 [1] 98 💬 |
212 |
Other: event-related evoked potential using electroencephalography (eeg). |
- |
- |
- |
- |
006 [1] 6 💬 |
213 |
Other: general population |
- |
- |
- |
- |
046 [2] 46, 271 💬 |
214 |
Other: glucose -potentiated arginine (gpa) stimulation tests |
Arginine |
[1] D02982 D02982 💬 |
- |
- |
299 [1] 299 💬 |
215 |
Other: histamine |
Histamine |
[1] D08040 D08040 💬 |
HRH1 [4] HRH1, HRH2, HRH3, HRH4 💬 |
Calcium signaling pathway [4] Calcium signaling pathway, Gastric acid secretion, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
013 [1] 13 💬 |
216 |
Other: hydroxychloroquine/chloroquine |
Chloroquine |
[4] D02125 D02125, D02366 D02366, D03469 D03469, D08050 D08050 💬 |
- |
- |
046 [1] 46 💬 |
217 |
Other: impact of biotherapy on postoperative morbidity in ulcerative colitis |
- |
- |
- |
- |
097 [1] 97 💬 |
218 |
Other: losartan |
Losartan |
[2] D00357 D00357, D08146 D08146 💬 |
AGTR1 [1] AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
046 [1] 46 💬 |
219 |
Other: position sense |
- |
- |
- |
- |
013 [1] 13 💬 |
220 |
Other: postoperative nausea and vomiting at 24 hour |
- |
- |
- |
- |
235 [1] 235 💬 |
221 |
Other: postoperative nausea and vomiting at 6 hour |
- |
- |
- |
- |
235 [1] 235 💬 |
222 |
Other: postoperative pain at 24 hour |
- |
- |
- |
- |
235 [1] 235 💬 |
223 |
Other: postoperative pain at 6 hour |
- |
- |
- |
- |
235 [1] 235 💬 |
224 |
Other: postoperative sore throat and hoarseness at 24 hour |
- |
- |
- |
- |
235 [1] 235 💬 |
225 |
Other: postoperative sore throat and hoarseness at 6 hour |
- |
- |
- |
- |
235 [1] 235 💬 |
226 |
Other: potable water |
Water |
[1] D00001 D00001 💬 |
- |
- |
019 [1] 19 💬 |
227 |
Other: reaction time and postural control |
- |
- |
- |
- |
299 [1] 299 💬 |
228 |
Other: review of past medical history, clinical exam, and electroencephalogram, polysomnography and urine samples of melatonin and pupillometry. |
Melatonin |
[1] D08170 D08170 💬 |
MTNR1A [2] MTNR1A, MTNR1B 💬 |
Circadian entrainment [2] Circadian entrainment, Neuroactive ligand-receptor interaction |
149 [1] 149 💬 |
229 |
Other: sulfur pool & medicinal mud |
- |
- |
- |
- |
046 [1] 46 💬 |
230 |
Other: tobramycin time of administration |
Tobramycin |
[2] D00063 D00063, D02542 D02542 💬 |
- |
- |
299 [1] 299 💬 |
231 |
Other: trunk position sense |
- |
- |
- |
- |
013 [1] 13 💬 |
232 |
Other: use of a postpartum diary and additional blood draws |
- |
- |
- |
- |
288 [1] 288 💬 |
233 |
Other: use of a postpartum diary and additional blood draws. |
- |
- |
- |
- |
288 [1] 288 💬 |
234 |
Ovastat 1000 mg, powder for solution for infusion |
Treosulfan |
[1] D07253 D07253 💬 |
- |
- |
065 [1] 65 💬 |
235 |
Ovastat 5000 mg, powder for solution for infusion |
Treosulfan |
[1] D07253 D07253 💬 |
- |
- |
065 [1] 65 💬 |
236 |
Paclitaxel |
Paclitaxel |
[2] D00491 D00491, D05333 D05333 💬 |
TUBB [9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 |
Alzheimer disease [10] Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection |
046 [2] 46, 85 💬 |
237 |
Pancreas powder |
- |
- |
- |
- |
299 [1] 299 💬 |
238 |
Pancreatin (pancreas powder) |
Pancrelipase |
[1] D05349 D05349 💬 |
- |
- |
299 [1] 299 💬 |
239 |
Pancreatina (páncreas polvo |
- |
- |
- |
- |
299 [1] 299 💬 |
240 |
Pancreatina (páncreas polvo) |
- |
- |
- |
- |
299 [1] 299 💬 |
241 |
Pancrelipase/pancreas powder |
Pancrelipase |
[1] D05349 D05349 💬 |
- |
- |
298 [2] 298, 299 💬 |
242 |
Pegylated polypeptide hormone of human recombinant origin peg-hgh |
- |
- |
- |
- |
078 [1] 78 💬 |
243 |
Pemirolast |
Pemirolast |
[2] D01088 D01088, D07476 D07476 💬 |
- |
- |
113 [1] 113 💬 |
244 |
Pentosan polysulfat sp 54® injection solution |
- |
- |
- |
- |
019 [1] 19 💬 |
245 |
Pentosan polysulfate |
Pentosan polysulfate |
[1] D05428 D05428 💬 |
- |
- |
019 [3] 19, 26, 226 💬 |
246 |
Pentosan polysulfate sodium |
Pentosan polysulfate |
[1] D05428 D05428 💬 |
- |
- |
019 [1] 19 💬 |
247 |
Pentosan polysulfate sodium 100 mg |
Pentosan polysulfate |
[1] D05428 D05428 💬 |
- |
- |
226 [1] 226 💬 |
248 |
Pentosan polysulphate sp54 |
- |
- |
- |
- |
019 [1] 19 💬 |
249 |
Pentosan polysulphate sp54® |
- |
- |
- |
- |
019 [1] 19 💬 |
250 |
Piperacilline/tazobactam fresenius kabi 2 g/0,25 g poeder voor oplossing voor infusie |
Tazobactam |
[1] D00660 D00660 💬 |
- |
- |
299 [1] 299 💬 |
251 |
Piperacilline/tazobactam fresenius kabi 4 g/0,5 g poeder voor oplossing voor infusie |
Tazobactam |
[1] D00660 D00660 💬 |
- |
- |
299 [1] 299 💬 |
252 |
Plaquenil - hydroxychloroquine 200mg film coated tablets |
Hydroxychloroquine |
[1] D08050 D08050 💬 |
- |
- |
043 [3] 43, 44, 45 💬 |
253 |
Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) conjugated to crm197 carrier protein and adsorbed on aluminium phosphate |
Aluminium |
- |
- |
- |
046 [1] 46 💬 |
254 |
Pneumococcal polysaccharide serotype 1, 2, 3, 4, 5, 6b, 7f, 8, 9n, 9v, 10a, 11a, 12f, 14, 15b, 17f, 18c, 19a, 19f, 20, 22f, 23f and 33f |
- |
- |
- |
- |
046 [1] 46 💬 |
255 |
Pneumococcal polysaccharide serotype 1, 3, 4, 5, 6a, 6b, 7f, 9v, 14, 18c, 19a, 19f and 23f |
- |
- |
- |
- |
046 [1] 46 💬 |
256 |
Pneumococcal polysaccharide vaccine |
- |
- |
- |
- |
046 [1] 46 💬 |
257 |
Pneumococcal polysaccharide vaccine (23 valent) |
- |
- |
- |
- |
046 [1] 46 💬 |
258 |
Pneumococcal polysaccharide vaccine 23 valent |
- |
- |
- |
- |
265 [1] 265 💬 |
259 |
Po |
- |
- |
- |
- |
013 [1] 13 💬 |
260 |
Po azithromycin |
Azithromycin |
[3] D02134 D02134, D06390 D06390, D07486 D07486 💬 |
- |
- |
299 [1] 299 💬 |
261 |
Po ciprofloxacin |
Ciprofloxacin |
[2] D00186 D00186, D02216 D02216 💬 |
- |
- |
299 [1] 299 💬 |
262 |
Pol6014 |
- |
- |
- |
- |
299 [1] 299 💬 |
263 |
Pol7080 |
- |
- |
- |
- |
299 [1] 299 💬 |
264 |
Polaprezinc |
Polaprezinc |
[1] D01611 D01611 💬 |
- |
- |
096 [2] 96, 97 💬 |
265 |
Polidocanol |
Polidocanol |
[1] D01993 D01993 💬 |
- |
- |
279 [1] 279 💬 |
266 |
Poly iclc |
- |
- |
- |
- |
034 [1] 34 💬 |
267 |
Poly(oxy-1,2-ethanediyl), a |
- |
- |
- |
- |
235 [1] 235 💬 |
268 |
Poly(oxy-1,2-ethanediyl), alpha-hydro-omega-methoxy, ether with n-[[[2-[[6-[[1-[3-[[3-(2,3-dihydroxypropoxy)propyl]amino]-3-oxopropyl]-2,5-dioxo-3-pyrrolidinyl]thio]hexyl]amino]ethyl]amino]carbonyl]-2-methylalanyl-teriparatide (2:1) |
Diethyl ether |
[2] D01772 D01772, D06078 D06078 💬 |
PTH1R [1] PTH1R 💬 |
Endocrine and other factor-regulated calcium reabsorption [3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
235 [1] 235 💬 |
269 |
Poly-l-lactic acid |
L-Lactic acid |
[1] D00111 D00111 💬 |
- |
- |
265 [1] 265 💬 |
270 |
Polyclonal igg |
- |
- |
- |
- |
065 [1] 65 💬 |
271 |
Polydeoxyribonucleotides |
- |
- |
- |
- |
051 [2] 51, 70 💬 |
272 |
Polyethylene glycol |
Polyethylene glycol |
[1] D03370 D03370 💬 |
- |
- |
096 [5] 96, 97, 235, 276, 299 💬 |
273 |
Polyethylene glycol 3350 |
Polyethylene glycol |
[1] D03370 D03370 💬 |
- |
- |
096 [2] 96, 299 💬 |
274 |
Polymva |
- |
- |
- |
- |
002 [1] 2 💬 |
275 |
Polyphenon e |
- |
- |
- |
- |
013 [2] 13, 36 💬 |
276 |
Polyphenon e® |
- |
- |
- |
- |
097 [1] 97 💬 |
277 |
Pomalidomida |
Pomalidomide |
[1] D08976 D08976 💬 |
IL6 [2] IL6, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [78] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
051 [1] 51 💬 |
278 |
Pomalidomide |
Pomalidomide |
[1] D08976 D08976 💬 |
IL6 [2] IL6, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [78] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
028 [6] 28, 34, 51, 85, 227, 331 💬 |
279 |
Pomalidomide (cc-4047 |
Pomalidomide |
[1] D08976 D08976 💬 |
IL6 [2] IL6, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [78] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
085 [1] 85 💬 |
280 |
Pomalidomide (cc-4047) |
Pomalidomide |
[1] D08976 D08976 💬 |
IL6 [2] IL6, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [78] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
051 [1] 51 💬 |
281 |
Pomalidomide and dexamethasone |
Dexamethasone |
[10] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D08976 D08976 💬 |
IL6 [3] IL6, NR3C1, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [79] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
028 [1] 28 💬 |
282 |
Pomalidomide oral product |
Pomalidomide |
[1] D08976 D08976 💬 |
IL6 [2] IL6, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [78] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
227 [1] 227 💬 |
283 |
Pomegranate |
Pomegranate |
- |
- |
- |
096 [2] 96, 97 💬 |
284 |
Ponesimod |
Ponesimod |
[1] D11215 D11215 💬 |
S1PR1 [1] S1PR1 💬 |
FoxO signaling pathway [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 [1] 13 💬 |
285 |
Ponesimod 10 mg |
Ponesimod |
[1] D11215 D11215 💬 |
S1PR1 [1] S1PR1 💬 |
FoxO signaling pathway [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 [1] 13 💬 |
286 |
Ponesimod 20 mg |
Ponesimod |
[1] D11215 D11215 💬 |
S1PR1 [1] S1PR1 💬 |
FoxO signaling pathway [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 [1] 13 💬 |
287 |
Ponesimod 40 mg |
Ponesimod |
[1] D11215 D11215 💬 |
S1PR1 [1] S1PR1 💬 |
FoxO signaling pathway [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 [1] 13 💬 |
288 |
Ponticelli regimen |
- |
- |
- |
- |
222 [1] 222 💬 |
289 |
Pooled mesenchymal stem cell |
- |
- |
- |
- |
049 [1] 49 💬 |
290 |
Pooled plasma (human), solvent/detergent treated |
- |
- |
- |
- |
064 [1] 64 💬 |
291 |
Porcine (pig) pert |
- |
- |
- |
- |
299 [1] 299 💬 |
292 |
Porcine pert |
- |
- |
- |
- |
299 [1] 299 💬 |
293 |
Porphobilinogen |
Porphobilinogen |
- |
- |
- |
254 [1] 254 💬 |
294 |
Posaconazole |
Posaconazole |
[1] D02555 D02555 💬 |
- |
- |
060 [3] 60, 65, 299 💬 |
295 |
Posaconazole (psz) |
Posaconazole |
[1] D02555 D02555 💬 |
- |
- |
065 [1] 65 💬 |
296 |
Posaconazolo |
- |
- |
- |
- |
299 [1] 299 💬 |
297 |
Posiphen |
Posiphen |
- |
- |
- |
006 [1] 6 💬 |
298 |
Positron emission tomography using [11 carbon]-3-amino-4-(2-dimethylaminomethylphenylsulfanyl)-benzonitrile ([11c]-dasb) and [18 fluorine]-altanserin ([18f]-altanserin) |
Activated charcoal |
[1] D03251 D03251 💬 |
- |
- |
006 [1] 6 💬 |
299 |
Positron emission tomography using [18 fluorine]-altanserin ([18f]-altanserin) |
- |
- |
- |
- |
006 [1] 6 💬 |
300 |
Postoperative 3-month exclusive enteral nutrition |
- |
- |
- |
- |
096 [1] 96 💬 |
301 |
Potassium |
Potassium |
[1] D08403 D08403 💬 |
- |
- |
036 [10] 36, 46, 66, 67, 98, 115, 167, 179, 215, 235 💬 |
302 |
Potassium sparing diuretic |
Potassium |
[1] D08403 D08403 💬 |
- |
- |
235 [1] 235 💬 |
303 |
Potassium supplement |
Potassium |
[1] D08403 D08403 💬 |
- |
- |
046 [1] 46 💬 |
304 |
Potiga |
- |
- |
- |
- |
144 [1] 144 💬 |
305 |
Powder for oral suspension) |
- |
- |
- |
- |
113 [1] 113 💬 |
306 |
Prednison 5, 20 léciva por. tablet nob |
- |
- |
- |
- |
050 [1] 50 💬 |
307 |
Prednison 5, 20 léciva por. tablet nob. |
- |
- |
- |
- |
050 [1] 50 💬 |
308 |
Privigen 100 mg/ml, solution pour perfusion |
- |
- |
- |
- |
053 [1] 53 💬 |
309 |
Procedure: blood collection for pk testing (15 minutes post injection) |
- |
- |
- |
- |
046 [1] 46 💬 |
310 |
Procedure: blood collection for pk testing (18-20 hours post injection) |
- |
- |
- |
- |
046 [1] 46 💬 |
311 |
Procedure: blood collection for pk testing (180 minutes post injection) |
- |
- |
- |
- |
046 [1] 46 💬 |
312 |
Procedure: blood collection for pk testing (60 minutes post injection) |
- |
- |
- |
- |
046 [1] 46 💬 |
313 |
Procedure: injections on posterior bladder wall excluding the trigone |
- |
- |
- |
- |
226 [1] 226 💬 |
314 |
Procedure: positron emission tomography |
- |
- |
- |
- |
040 [4] 40, 46, 49, 96 💬 |
315 |
Procedure: posterior ra |
- |
- |
- |
- |
075 [1] 75 💬 |
316 |
Procedure: posterolateral spinal fusion with instrumentation |
- |
- |
- |
- |
070 [1] 70 💬 |
317 |
Procedure: power doppler ultrasonography |
- |
- |
- |
- |
046 [1] 46 💬 |
318 |
Procedure: spect imaging (180 minutes post-injection) |
- |
- |
- |
- |
046 [1] 46 💬 |
319 |
Procedure: spect imaging (60 minutes post-injection) |
- |
- |
- |
- |
046 [1] 46 💬 |
320 |
Procedure: status post lung transplant |
- |
- |
- |
- |
228 [1] 228 💬 |
321 |
Procedure: whole body planar spect imaging (15 minutes post-injection) |
- |
- |
- |
- |
046 [1] 46 💬 |
322 |
Procedure: whole body planar spect imaging (18-20 hours post-injection) |
- |
- |
- |
- |
046 [1] 46 💬 |
323 |
Procedure: whole body planar spect imaging (180 minutes post-injection) |
- |
- |
- |
- |
046 [1] 46 💬 |
324 |
Procedure: whole body planar spect imaging (60 minutes post-injection) |
- |
- |
- |
- |
046 [1] 46 💬 |
325 |
Promixin 1 million international units (iu) powder for nebuliser solution |
- |
- |
- |
- |
299 [1] 299 💬 |
326 |
Promixin, 1 million international units (iu) powder for nebuliser solution |
- |
- |
- |
- |
299 [1] 299 💬 |
327 |
Promixin,1 millón de unidades internacionales,polvo para solución para inhalación por nebulizador |
- |
- |
- |
- |
299 [1] 299 💬 |
328 |
Prophylactic vaccine (tetanus, diphtheria, pertussis, poliomyelitis, influenza, hepatitis a, hepatitis b, tick-borne encephalitis, meningococcal, pneumococcal) |
- |
- |
- |
- |
013 [1] 13 💬 |
329 |
Pseudoephedrine |
Pseudoephedrine |
[4] D00485 D00485, D05648 D05648, D05649 D05649, D08449 D08449 💬 |
ADRA1A [9] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 |
AMPK signaling pathway [13] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
017 [1] 17 💬 |
330 |
Pseudoephedrine + 480 ml water |
Pseudoephedrine |
[5] D00001 D00001, D00485 D00485, D05648 D05648, D05649 D05649, D08449 D08449 💬 |
ADRA1A [9] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 |
AMPK signaling pathway [13] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
017 [1] 17 💬 |
331 |
Pseudoephedrine + 50 ml water |
Pseudoephedrine |
[5] D00001 D00001, D00485 D00485, D05648 D05648, D05649 D05649, D08449 D08449 💬 |
ADRA1A [9] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 |
AMPK signaling pathway [13] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
017 [1] 17 💬 |
332 |
Psyllium husk powder |
Plantago seed |
[1] D05525 D05525 💬 |
- |
- |
097 [1] 97 💬 |
333 |
Quinidine |
Quinidine |
[4] D00642 D00642, D00643 D00643, D02272 D02272, D08458 D08458 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
002 [3] 2 , 8 , 13 💬 |
334 |
Quinidine sulfate |
Quinidine |
[4] D00642 D00642, D00643 D00643, D02272 D02272, D08458 D08458 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
013 [1] 13 💬 |
335 |
Radiation: pet (positron emission tomography) study |
- |
- |
- |
- |
017 [1] 17 💬 |
336 |
Radiolabelled oligog cf-5/20 dry powder for inhalation (dpi) |
- |
- |
- |
- |
299 [1] 299 💬 |
337 |
Raptiva 100 mg/ml powder and solvent for solution for injection |
- |
- |
- |
- |
011 [7] 11, 13, 46, 53, 61, 95, 96 💬 |
338 |
Recombinant human porphobilinogen deaminase (porphozym) |
Porphobilinogen |
- |
- |
- |
254 [1] 254 💬 |
339 |
Recombinant porcine coagulation factor viii (b domain deleted) |
Beroctocog alfa |
- |
- |
- |
288 [1] 288 💬 |
340 |
Recombinant porcine coagulation factor viii (b-domain deleted) |
Beroctocog alfa |
- |
- |
- |
288 [1] 288 💬 |
341 |
Remicade 100 mg polvo para concentrado para solución para perfusión |
- |
- |
- |
- |
046 [2] 46, 271 💬 |
342 |
Remicade 100 mg powder for concentrate for solution for infusion. |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
343 |
Remsima - 100 mg polvere per concentrato per soluzione per infusione - uso endovenoso - flanconcino (vetro) - 1 flaconcino |
- |
- |
- |
- |
046 [4] 46, 96, 97, 271 💬 |
344 |
Retigabine/ezogabine |
Ezogabine |
[1] D09569 D09569 💬 |
KCNQ1 [5] KCNQ1, KCNQ2, KCNQ3, KCNQ4, KCNQ5 💬 |
Adrenergic signaling in cardiomyocytes [6] Adrenergic signaling in cardiomyocytes, Cholinergic synapse, Gastric acid secretion, Pancreatic secretion, Protein digestion and absorption, Vibrio cholerae infection |
144 [1] 144 💬 |
345 |
Revatio 10 mg/ml powder for oral suspension |
- |
- |
- |
- |
086 [1] 86 💬 |
346 |
Revatio pos |
- |
- |
- |
- |
086 [1] 86 💬 |
347 |
Rt234 - vardenafil inhalation powder |
Vardenafil |
[3] D02731 D02731, D03260 D03260, D08668 D08668 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
348 |
S-warfarin |
Warfarin |
[3] D00564 D00564, D01280 D01280, D08682 D08682 💬 |
NQO1 [2] NQO1, VKORC1 💬 |
Biosynthesis of cofactors [6] Biosynthesis of cofactors, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis |
013 [1] 13 💬 |
349 |
Saizen 8mg click.easy powder for solution for injection |
- |
- |
- |
- |
078 [1] 78 💬 |
350 |
Saizen 8mg click.easy power for solution for injection |
- |
- |
- |
- |
078 [1] 78 💬 |
351 |
Sandostatina - lar 20 mg/2.5 ml polvere e solvente per sospensione iniettabile flacone polvere + siringa preriempita 2.5 ml + 2 aghi |
- |
- |
- |
- |
067 [1] 67 💬 |
352 |
Sildenafil and losartan |
Losartan |
[4] D00357 D00357, D02229 D02229, D08146 D08146, D08514 D08514 💬 |
AGTR1 [2] AGTR1, PDE5A 💬 |
AGE-RAGE signaling pathway in diabetic complications [18] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Purine metabolism, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
085 [1] 85 💬 |
353 |
Sinvastatina sandoz 40 mg comprimidos revestidos por película |
- |
- |
- |
- |
013 [1] 13 💬 |
354 |
Sirolimus and hydroxychloroquine 200 mg |
Hydroxychloroquine |
[2] D00753 D00753, D08050 D08050 💬 |
MTOR [1] MTOR 💬 |
AMPK signaling pathway [50] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
089 [1] 89 💬 |
355 |
Sirolimus and hydroxychloroquine 400 mg |
Hydroxychloroquine |
[2] D00753 D00753, D08050 D08050 💬 |
MTOR [1] MTOR 💬 |
AMPK signaling pathway [50] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
089 [1] 89 💬 |
356 |
Solu medrol - 125 mg/2 ml polvere e solvente per soluzione iniettabile 1 flacone a doppia camera da 125 mg/2 ml |
- |
- |
- |
- |
013 [3] 13, 14, 53 💬 |
357 |
Solu-cortef, powder for solution for injection, 100mg, and 'act-o-vial' |
- |
- |
- |
- |
006 [1] 6 💬 |
358 |
Spd476 is a polymeric matrix formulation that displays both delayed- and extended-release of mesalazine |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
359 |
Sulphasalazine + hydroxychloroquine or prednisolone |
Hydroxychloroquine |
[9] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301, D08050 D08050 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
360 |
Sweet polvilho |
- |
- |
- |
- |
257 [1] 257 💬 |
361 |
Synthetic 15-amino-acid macrocyclic peptide acylated with a polyethyleneglycol palmitoylated linker |
- |
- |
- |
- |
062 [1] 62 💬 |
362 |
Takecab tablets + amoxicillin + clarithromycin (first-line eradication) takecab tablets + amoxicillin + metronidazole (second-line eradication) |
Amoxicillin |
[7] D00229 D00229, D00276 D00276, D00409 D00409, D02925 D02925, D05016 D05016, D05017 D05017, D07452 D07452 💬 |
- |
- |
063 [1] 63 💬 |
363 |
Tedizolid po |
Tedizolid |
[1] D09685 D09685 💬 |
- |
- |
299 [1] 299 💬 |
364 |
Teicoplanin sandoz 200 mg powder and solvent for solution for injection or infusion or oral solution. |
Teicoplanin |
[1] D02142 D02142 💬 |
- |
- |
299 [1] 299 💬 |
365 |
Teriparatide conjugated to a multiarm polyethylene glycol carrier molecule through a cleavable linker |
Polyethylene glycol |
[2] D03370 D03370, D06078 D06078 💬 |
PTH1R [1] PTH1R 💬 |
Endocrine and other factor-regulated calcium reabsorption [3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
235 [1] 235 💬 |
366 |
The generic name is warfarin and many producers will be involved |
Warfarin |
[3] D00564 D00564, D01280 D01280, D08682 D08682 💬 |
NQO1 [2] NQO1, VKORC1 💬 |
Biosynthesis of cofactors [6] Biosynthesis of cofactors, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis |
049 [1] 49 💬 |
367 |
The investigational medicinal product (imp) may be labelled as either pf-04236921 106 mg/vial, clonal sc lyophilized form” or pf-04236921 powder for injection, 106 mg/vial”. supplies labelled with either nomenclature are equivalent. |
- |
- |
- |
- |
096 [1] 96 💬 |
368 |
The investigational medicinal product (imp) will be labeled as pf-04236921 106 mg/vial, clonal sc lyophilized form, which is equivalent to pf-04236921 powder for injection, 106 mg/vial as described in the enclosed cta |
- |
- |
- |
- |
096 [1] 96 💬 |
369 |
The investigational medicinal product (imp) will be labeled as pf-04236921 106 mg/vial, clonal sc lyophilized form, which is equivalent to pf-04236921 powder for injection, 106 mg/vial as described in the enclosed cta. |
- |
- |
- |
- |
096 [1] 96 💬 |
370 |
The pop02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the following drugs of interest per standard of care: |
- |
- |
- |
- |
086 [1] 86 💬 |
371 |
The pops study is collecting pk data on children prescribed the following drugs of interest per standard of care: |
- |
- |
- |
- |
086 [1] 86 💬 |
372 |
Tip (tobramycin inhalation powder) |
Tobramycin |
[2] D00063 D00063, D02542 D02542 💬 |
- |
- |
299 [1] 299 💬 |
373 |
Tis (tobramycin inhalation solution) |
Tobramycin |
[2] D00063 D00063, D02542 D02542 💬 |
- |
- |
299 [1] 299 💬 |
374 |
Tobi (tobramycin) |
Tobramycin |
[2] D00063 D00063, D02542 D02542 💬 |
- |
- |
299 [1] 299 💬 |
375 |
Tobi 300 mg/5 ml solución para inhalación por nebulizador |
- |
- |
- |
- |
299 [1] 299 💬 |
376 |
Tobi 300 mg/5 ml, solution pour inhalation par nébuliseur |
- |
- |
- |
- |
299 [1] 299 💬 |
377 |
Tobi 300mg/5ml solución para inhalación por nebulizador. |
- |
- |
- |
- |
299 [1] 299 💬 |
378 |
Tobi podhaler |
- |
- |
- |
- |
299 [1] 299 💬 |
379 |
Tobi podhaler - 28 mg polvere per inalazione capsula rigida uso inalatorio blister(alu/alu) 56 capsule + 1 inalatore |
- |
- |
- |
- |
299 [1] 299 💬 |
380 |
Tobi podhaler 28 mg hartkapseln mit pulver zur inhalation |
- |
- |
- |
- |
299 [1] 299 💬 |
381 |
Tobi podhaler 28 mg inhalációs por, kemény kapszula |
- |
- |
- |
- |
299 [1] 299 💬 |
382 |
Tobi podhaler*448cps 28mg+10in |
- |
- |
- |
- |
299 [1] 299 💬 |
383 |
Tobi™ podhaler™ 112 mg inhaled twice daily |
- |
- |
- |
- |
299 [1] 299 💬 |
384 |
Tobramicina polvere inalatoria |
Tobramycin |
[2] D00063 D00063, D02542 D02542 💬 |
- |
- |
299 [1] 299 💬 |
385 |
Tobramycin |
Tobramycin |
[2] D00063 D00063, D02542 D02542 💬 |
- |
- |
299 [1] 299 💬 |
386 |
Tobramycin (gernebcin®) |
Tobramycin |
[2] D00063 D00063, D02542 D02542 💬 |
- |
- |
299 [1] 299 💬 |
387 |
Tobramycin / bramitob |
Tobramycin |
[2] D00063 D00063, D02542 D02542 💬 |
- |
- |
299 [1] 299 💬 |
388 |
Tobramycin / tobi |
Tobramycin |
[2] D00063 D00063, D02542 D02542 💬 |
- |
- |
299 [1] 299 💬 |
389 |
Tobramycin 100 pari |
Tobramycin |
[2] D00063 D00063, D02542 D02542 💬 |
- |
- |
299 [1] 299 💬 |
390 |
Tobramycin dry powder |
Tobramycin |
[2] D00063 D00063, D02542 D02542 💬 |
- |
- |
299 [1] 299 💬 |
391 |
Tobramycin for inhalation |
Tobramycin |
[2] D00063 D00063, D02542 D02542 💬 |
- |
- |
299 [1] 299 💬 |
392 |
Tobramycin inhalation powder |
Tobramycin |
[2] D00063 D00063, D02542 D02542 💬 |
- |
- |
299 [1] 299 💬 |
393 |
Tobramycin inhalation powder (tip) |
Tobramycin |
[2] D00063 D00063, D02542 D02542 💬 |
- |
- |
299 [1] 299 💬 |
394 |
Tobramycin inhalation powder tip delivered by the t-326 inhaler |
Tobramycin |
[2] D00063 D00063, D02542 D02542 💬 |
- |
- |
299 [1] 299 💬 |
395 |
Tobramycin inhalation solution |
Tobramycin |
[2] D00063 D00063, D02542 D02542 💬 |
- |
- |
299 [1] 299 💬 |
396 |
Tobramycin inhalation solution (tis) |
Tobramycin |
[2] D00063 D00063, D02542 D02542 💬 |
- |
- |
299 [1] 299 💬 |
397 |
Tobramycin inhalation solution using a pari lc® plus nebulizer. |
Tobramycin |
[2] D00063 D00063, D02542 D02542 💬 |
- |
- |
299 [1] 299 💬 |
398 |
Tobramycin injection 40mg/1ml |
Tobramycin |
[2] D00063 D00063, D02542 D02542 💬 |
- |
- |
299 [1] 299 💬 |
399 |
Tobramycin nebulized nasally |
Tobramycin |
[2] D00063 D00063, D02542 D02542 💬 |
- |
- |
299 [1] 299 💬 |
400 |
Tobramycin powder |
Tobramycin |
[2] D00063 D00063, D02542 D02542 💬 |
- |
- |
299 [1] 299 💬 |
401 |
Tobramycin solution for inhalation |
Tobramycin |
[2] D00063 D00063, D02542 D02542 💬 |
- |
- |
299 [1] 299 💬 |
402 |
Tobramycin solution for inhalation (tobi) |
Tobramycin |
[2] D00063 D00063, D02542 D02542 💬 |
- |
- |
299 [1] 299 💬 |
403 |
Tobramycin solution for inhalation 300 mg |
Tobramycin |
[2] D00063 D00063, D02542 D02542 💬 |
- |
- |
299 [1] 299 💬 |
404 |
Tobramycin steri-neb 300 mg/5 ml, inhalation solution |
Tobramycin |
[2] D00063 D00063, D02542 D02542 💬 |
- |
- |
299 [1] 299 💬 |
405 |
Tobramycin sulfate |
Sulfate ion |
[2] D00063 D00063, D02542 D02542 💬 |
- |
- |
299 [1] 299 💬 |
406 |
Tofacitinib 5mg po bid |
Tofacitinib |
[1] D09970 D09970 💬 |
JAK1 [4] JAK1, JAK2, JAK3, TYK2 💬 |
AGE-RAGE signaling pathway in diabetic complications [35] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
046 [1] 46 💬 |
407 |
Topotecan |
Topotecan |
[2] D02168 D02168, D08618 D08618 💬 |
- |
- |
025 [1] 25 💬 |
408 |
Transdermal nicotine |
Nicotine |
[3] D03365 D03365, D05156 D05156, D05157 D05157 💬 |
CHRNA1 [16] CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬 |
Alzheimer disease [7] Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases |
006 [1] 6 💬 |
409 |
Treatment with polyethylene glycol (macrogol 4000) |
Polyethylene glycol |
[1] D03370 D03370 💬 |
- |
- |
299 [1] 299 💬 |
410 |
Treprostinil inhalation powder |
Treprostinil |
[1] D06213 D06213 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
411 |
Tripterygium wilfordii polyglycosidium |
Tripterygium wilfordii whole |
- |
- |
- |
224 [1] 224 💬 |
412 |
Tysabri 300 mg solution à diluer pour perfusion |
- |
- |
- |
- |
013 [1] 13 💬 |
413 |
Vancomycin hydrochloride inhalation powder |
Vancomycin |
[2] D00212 D00212, D00926 D00926 💬 |
- |
- |
299 [1] 299 💬 |
414 |
Vancomycin inhalation powder |
Vancomycin |
[2] D00212 D00212, D00926 D00926 💬 |
- |
- |
299 [1] 299 💬 |
415 |
Vantobra (tobramycin) |
Tobramycin |
[2] D00063 D00063, D02542 D02542 💬 |
- |
- |
299 [1] 299 💬 |
416 |
Versus hydroxychloroquine |
Hydroxychloroquine |
[1] D08050 D08050 💬 |
- |
- |
049 [1] 49 💬 |
417 |
Veyondi 650iu powder and solvent for solution for injection |
- |
- |
- |
- |
288 [1] 288 💬 |
418 |
Veyvondi 1300iu powder and solvent for solution for injection |
- |
- |
- |
- |
288 [1] 288 💬 |
419 |
Veyvondi 650iu powder and solvent for solution for injection |
- |
- |
- |
- |
288 [1] 288 💬 |
420 |
Vfend 40 mg/ml powder for oral suspension |
- |
- |
- |
- |
299 [1] 299 💬 |
421 |
Vitamin d powder |
Vitamin D |
- |
- |
- |
299 [1] 299 💬 |
422 |
Vpriv - 400 u - polvere per soluzione per infusione - uso endovenoso - flaconcino(vetro) 1 flaconcino |
- |
- |
- |
- |
019 [1] 19 💬 |
423 |
Vpriv 400 units powder for solution of infusion |
- |
- |
- |
- |
019 [1] 19 💬 |
424 |
Warfarin |
Warfarin |
[3] D00564 D00564, D01280 D01280, D08682 D08682 💬 |
NQO1 [2] NQO1, VKORC1 💬 |
Biosynthesis of cofactors [6] Biosynthesis of cofactors, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis |
006 [11] 6 , 8 , 13, 19, 46, 49, 66, 85, 88, 96, 97 💬 |
425 |
Warfarin 10 mg |
Warfarin |
[3] D00564 D00564, D01280 D01280, D08682 D08682 💬 |
NQO1 [2] NQO1, VKORC1 💬 |
Biosynthesis of cofactors [6] Biosynthesis of cofactors, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis |
096 [2] 96, 97 💬 |
426 |
Warfarin sodium |
Warfarin |
[3] D00564 D00564, D01280 D01280, D08682 D08682 💬 |
NQO1 [2] NQO1, VKORC1 💬 |
Biosynthesis of cofactors [6] Biosynthesis of cofactors, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis |
049 [1] 49 💬 |
427 |
Warfarin+ vitamin k |
Phylloquinone |
[4] D00148 D00148, D00564 D00564, D01280 D01280, D08682 D08682 💬 |
NQO1 [2] NQO1, VKORC1 💬 |
Biosynthesis of cofactors [6] Biosynthesis of cofactors, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis |
046 [1] 46 💬 |
428 |
Wuling powder |
- |
- |
- |
- |
006 [1] 6 💬 |
429 |
Yondelis 0,25 mg polvo para concentrado para solución para perfusión |
- |
- |
- |
- |
159 [1] 159 💬 |
430 |
Yondelis 0.25 mg powder for concentrate for solution for infusion. |
- |
- |
- |
- |
159 [1] 159 💬 |
431 |
Yondelis 1 mg polvo para concentrado para solución para perfusión |
- |
- |
- |
- |
159 [1] 159 💬 |
432 |
Yondelis 1 mg powder for concentrate for solution for infusion. |
- |
- |
- |
- |
159 [1] 159 💬 |
433 |
Zx008 (fenfluramine hydrochloride) |
Fenfluramine |
[1] D07945 D07945 💬 |
HTR2A [4] HTR2A, HTR2B, HTR2C, SLC6A4 💬 |
Calcium signaling pathway [6] Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle |
140 [2] 140, 144 💬 |